Jul 06, 2009
Amazing information about Birth control everyone should know, pass it on, no matter what you deside.
The Mechanisms of the pill and BC
According to definition, an effective contraceptive would absolutely prevent conception--it would suppress or inhibit ovulation, making it impossible for sperm to meet with eggs. The only products falling into this category are jellies and foams--spermicides--and condoms. (Diaphragms are considered a mechanical barrier and not true contraceptives. But they are not abortifacients either.
Today's birth control pills are not the same "Pill" of the 1960s. That first pill with its high dose of hormones did prevent ovulation in the majority but not all) of its users, and conception. In the mid-'70s, because of the dangerous side effects associated with the high-dose "Pill." the pharmaceutical companies started reducing the doses of the hormones estrogen and progestin from 150 micrograms down to 35 micrograms by 1988. Now'. some are as low as 20 micrograms.
BCPs today work in one of three ways: by suppressing or inhibiting ovulation so that fertilization is impeded: altering cervical mucus to reduce sperm migration: or via a backup mechanism that prevents implantation of the newly conceived human life in the lining of the womb by creating a chemically hostile environment, sometimes called a post-fertilization effect In 1994, Dr. Thomas Hilgers, a respected fertility specialist and clinical professor in the Department of Obstetrics and Gynecology at Creighton University School of Medicine. said. "All birth control pills available have a mechanism which disturbs or disintegrates the lining of the uterus to the extent that the possibility of abortion exists when break-through ovulation occurs." (Break-through ovulation is the term used when the contraceptive component of the pill has failed, allowing ovulation and therefore conception to take place.)
Pharmaceutical company statements, medical textbooks, doctors, scientists, and even the government show total agreement when it comes to the abortifacient nature of the backup mechanism. Dr. Leon Speroff, the nation's premier contraceptive expert and advocate, in his paper A Clinical Guide for Contraception, says about BCPs, "The progestin in the combination pill produces an endometrium which is not receptive to ovum implantation, a decidualized bed with exhausted and atrophied glands." Dutch gynecologist Dr. Nine Van Der Vange of the Society for Advancement in Contraception said, "The contraceptive preparations are more complex than has been thought. They are not only based on inhibition of ovulation."
Searle, Ortho, and Wyeth-Ayerst, major manufacturers of BCPs, admit in the fine print of some of their package inserts that alterations in the endometrium (uterine lining) reduce the likelihood of "implantation" of the already conceived embryo. Wyeth-Ayerst says its product maximizes protection "by causing endometrial changes that will not support implantation." The Food and Drug Administration reported as early as 1976 that the pill changed "the characteristics of the uterus so that it is not receptive to a fertilized egg." And a standard medical reference, Danforth's Obstetrics and Gynecology, states, "The production of glycogen by the endometrial glands is diminished by the ingestion of oral contraceptives, which impairs the survival of the blastocyst in the uterine cavity." A blastocyst refers to a newly conceived human being.
While it is difficult to quantify the postfertilization effects of BCPs due to the failure of the contraceptive component, there is scientific research available to support the thesis that chemically induced abortions are probable. Dr. Van Der Vange conducted an award-winning study and showed, from research based on ultrasound exams and hormonal indicators, a 4.7 percent rate of breakthrough ovulation occurring in women who were given high-dose pills. Dr. Don Gambrell, Jr., a gynecological endocrinologist at the Medical College of Georgia in Augusta, noted a 14-percent incidence of breakthrough ovulation in women taking the relatively low dose 50-microgram BCPs in his research. Of course, the greater the rate of breakthrough ovulation, the greater the chance that the postfertilization mechanism would kick in to end the pregnancy.
Dr. Bogomir M. Kuhar, a doctor of pharmacy and director of Pharmacists for Life International, cited numerous studies by experts and pharmaceutical companies in his paper Infant Homicides Through Contraception. Dr. Kuhar concluded that the average rate of breakthrough ovulation due to a number of factors is between two percent and 10 percent per cycle. By factoring in a 25-percent overall conception rate for normally fertile couples per cycle with a user estimate of 13.9 million (Kuhar's article was written in 1993 so the user estimate might be lower than today's), and multiplying them, he deduced a two-percent rate would yield the potential for 69,500 chemical abortions per cycle or 834,000 per year, while the 10-percent rate would yield 347,500 per cycle or 4,171,000 chemical abortions per year--almost all of them due to the pill's abortifacient mechanisms. (Other factors such as naturally occurring miscarriages and surprise pregnancies would have some impact on the numbers.)
The longer-lasting (three months) Depo-Provera injection acts by altering the lining of the uterus, preventing implantation of the newly conceived life. Based on one million users with an ovulation rate of 40 to 60 percent, combined with a 25-percent conception rate, yields either 1.2 million chemical abortions per year, or on the higher end, 1.8 million a year. The popular Norplant, a subdermal implant of six tiny rods containing only progestin, acts up to five years as an abortifacient. With an ovulation rate of 50 to 60 percent, 2,250,000 to 2,925,000 chemical abortions might be the result.
The newer "mini-pill" uses only progestin as well, and is often given to postpartum women who are nursing their babies. Ovulation is estimated at taking place 67 to 81 percent of the time making the possibility of postfertilization effects high.
One thing is certain: there is no data that denies the existence of a potential post-conceptional effect; it simply cannot be ruled out. And there is evidence concerning a causal link between hormonal birth control and abortion, but nothing definitive. With the approval of RU-486 and methotrexate, both "morning after" drugs that kill the unborn swiftly and mercilessly, plus all 44 varieties of BCPs, implantable and injectable-style drugs, and the new "vaccines," the number of surgical abortions could now pale in comparison to the chemically aborted.